Phase 1b Study of Pasireotide, Everolimus, and Selective Internal Radioembolization Therapy for Unresectable Neuroendocrine Tumors With Hepatic Metastases
Cancer - United States
doi 10.1002/cncr.31192
Full Text
Open PDFAbstract
Available in full text
Date
February 16, 2018
Authors
Publisher
Wiley